A new coalition of biotechnology stakeholders has formed to promote development of new antibiotics to fight antimicrobial resistance.

The Centers for Disease Control and Prevention estimates more than 2 million Americans experience a drug-resistant infection annually, with at least 23,000 deaths. A new estimate from the Washington University School of Medicine in St. Louis puts the annual death toll as high as 162,000.

Working to Fight AMR launched in August to close the gap in the pharmacological arms race between deadly microbes and antibiotic treatments, the new coalition’s director told HealthLeaders last week.

More from HealthLeaders here.